We are looking for children and teens 2–17 years of age to join a study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or CD (including associated symptoms such as rectal bleeding, kidney stones, cramps, frequent fevers and/or anemia), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the CD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
